Dual GIP/GLP-1 Receptor Agonist12.5 mg

12.5 mg Tirzepatide Dosage Calculator

Calculate the precise unit measurement for your 12.5 mg tirzepatide escalation dose at any vial concentration.

050100

How many units is 12.5 mg of Tirzepatide at 5 mg/mL?

Draw

250units

2.50 mL on a U-100 insulin syringe

12.5 mg ÷ 5 mg/mL × 100 = 250 units

This dose exceeds 50 units (0.5 mL). Volumes greater than 0.5 mL may be uncomfortable for subcutaneous injection. Consult your provider about splitting the dose into two injections.

For educational purposes only. Always follow your provider's instructions.

Quick Reference Table

All dose × concentration combinations

Dose5 mg/mL10 mg/mL15 mg/mL25 mg/mL30 mg/mL60 mg/mL90 mg/mL100 mg/mL
2.5 mg502516.7108.34.22.82.5
5 mg100*5033.32016.78.35.65
7.5 mg150*75*50302512.58.37.5
10 mg200*100*66.7*4033.316.711.110
12.5 mg250*125*83.3*5041.720.813.912.5
15 mg300*150*100*60*502516.715

Values in U-100 insulin syringe units

* Exceeds 50 units (0.5 mL) — may require splitting into two injections

There's an easier way

Tired of calculating doses?

We handle everything — the prescription, the right dose, and shipping straight to your door. No math, no hassle.

Get Started

2-min quiz · Free consultation · No commitment

About the 12.5 mg Dose

The 12.5 mg dose is the penultimate escalation step for Mounjaro and Zepbound, used during weeks 17 through 20 before reaching the 15 mg maximum. Patients at this dose have been titrating for four months and are nearing the full therapeutic level. This dose bridges the gap between 10 mg and the 15 mg maintenance dose.

Frequently Asked Questions

In a 25 mg/mL vial, 12.5 mg tirzepatide equals 50 units. The calculation is (12.5 / 25) x 100 = 50 units. In a 30 mg/mL vial, it would be approximately 41.7 units, and in a 60 mg/mL vial, it would be approximately 20.8 units.

The 12.5 mg dose is used during weeks 17 through 20 of the Mounjaro and Zepbound titration schedule. It is the fifth of six dose levels, following 2.5 mg, 5 mg, 7.5 mg, and 10 mg. After 4 weeks at 12.5 mg, patients escalate to the 15 mg maintenance dose.

The 2.5 mg increment between 10 mg and 12.5 mg may seem small, but clinical data shows continued dose-dependent improvements in weight loss and glycemic control. Some patients who plateaued at 10 mg see renewed progress at 12.5 mg. The gradual escalation also helps manage the increased risk of gastrointestinal side effects.

Yes, some patients remain at 12.5 mg if they are achieving satisfactory weight loss or blood sugar control and prefer to avoid potential side effects at 15 mg. Your provider will evaluate your progress and tolerability to determine whether escalation to 15 mg is beneficial or if 12.5 mg is an appropriate long-term maintenance dose for you.

Other Tirzepatide Doses

2.5 mg Tirzepatide5 mg Tirzepatide7.5 mg Tirzepatide10 mg Tirzepatide15 mg Tirzepatide

Related Pages

Tirzepatide CalculatorTirzepatide Dosing

Ready to Get Started?

Take our 2-minute quiz to see if you qualify for GLP-1 treatment.

Start Quiz

Free consultation. No commitment.